In contrast, proneural tumors frequently harbor PDGFRA amplification or IDH1 mutations; the latter are characteristic of IDH-mutant gliomas and are associated with the CpG island methylator phenotype (G-CIMP), frequent MGMT promoter methylation, and comparatively favorable clinical outcomes [268,274]. The gene discussed is IDH1; the disease is glioma.